Notch signaling: Emerging molecular targets for cancer therapy

The Notch signaling pathway is a highly conserved developmental pathway, which plays a critical role in cell-fate decision, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a variety of malignancies, and can behave as either an oncogene or a tumo...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical pharmacology 2010-09, Vol.80 (5), p.690-701
Main Authors: Yin, Ling, Velazquez, Omaida C., Liu, Zhao-Jun
Format: Article
Language:English
Subjects:
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Cancer therapeutics
Humans
Neoplasms - drug therapy
Neoplasms - metabolism
Notch
Receptors, Notch - drug effects
Receptors, Notch - metabolism
Signal Transduction
Tumor
Tumor angiogenesis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Notch signaling pathway is a highly conserved developmental pathway, which plays a critical role in cell-fate decision, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a variety of malignancies, and can behave as either an oncogene or a tumor suppressor depending upon cell context. This review highlights the current evidence for aberration of the Notch signaling pathway in a wide range of tumors from hematological cancers, such as leukemia and lymphoma through to skin, breast, lung, pancreas, colon and brain tumors. It proposes that the Notch signaling pathway may represent novel therapeutic targets and will be a welcome asset to the cancer therapeutic arena.
ISSN:0006-2952
1873-2968
DOI:10.1016/j.bcp.2010.03.026